Molnupiravir Stella 200mg, a drug produced and registered by Stellapharm J.V.Co. Ltd., has been authorised by the Drug Administration of Vietnam (DAV) for the domestic treatment of COVID-19.
Despite an increasing number of COVID-19 cases recorded in Hanoi in recent days, the number of hospitalised patients has increased inconsiderably, while those at moderate level and above decreased slightly, according to statistics of the Ministry of Health (MoH).
The Drug Administration of Vietnam (DAV) under the Ministry of Health (MoH) has announced the prices of COVID-19 treatment drugs containing active ingredient Molnupiravir produced by three Vietnamese manufacturers.
The Drug Administration of Vietnam (DAV) under the Ministry of Health on February 17 issued the list of three COVID-19 treatment drugs containing the active ingredient Molnupiravir, which had been granted certificates of registration for conditional circulation.
Laos’ Ministry of Health has advised local residents to reduce the scale of festivals and only conduct traditional rituals during this year’s peak festival season in order to avoid mass gathering and prevent the spread of COVID-19 pandemic.
Laos is to step up production of its antiviral drug molnupiravir with the trade name of Molacovir to serve treatment of COVID-19 patients with mild symptoms.
An advisory council of the Ministry of Health (MoH) has proposed this ministry grant certificates of registration for conditional circulation of three medicines containing the active ingredient molnupiravir for COVID-19 treatment.
The Philippine House of Representatives has gone into lockdown to curb the spread of the Omicron variant of the coronavirus while Indonesia has reportedly prepared 120,000 hospital beds to cope with outbreaks caused by this new variant.
Prime Minister Pham Minh Chinh chaired a meeting on December 5 with ministries, sectors, and relevant sides to discuss COVID-19 vaccine and drug development, production technology transfer, and import.
Three pharmaceutical companies in Vietnam are planning to or are producing Molnupiravir pills to treat COVID-19 patients with mild or no symptoms, according to the Ministry of Health.
The Ministry of Health of Laos has given approval to the State Enterprise Pharmaceutical Factory No. 3 to produce molnupiravir pills to serve treatment of COVID-19.
Deputy Prime Minister Vu Duc Dam has asked for completion of the dossier of the homegrown Nano Covax vaccine to submit for urgent licencing, and assistance for relevant firms in testing the anti-virus drug Molnupiravir in a notice released by the Government Office.
Health
